Earlier quoted context omitted.
> It's not even close, for women age 20-29 the risk of fatal thrombosis is 1:250k I have yet to find a source that gives the risk for that cohort. > ...while Covid is somewhere around 1:25k Even if it's an order of magnitude higher, the risk of a actually getting a PCR-confirmed infection is an order of magnitude lower. Again, Germany: 28 deaths of women in that age group over the course of the pandemic[1], including…
> I have yet to find a source that gives the risk for that cohort. The data is publicly available for many countries, e.g. here for the UK: [1] Report on adverse reactions until 16 Jun 2021 https://www.gov.uk/government/publications/coronavirus-covid... [2] Vaccination statistics https://www.england.nhs.uk/statistics/statistical-work-areas... Check the table with reports and fatalities by age, and the paragraph inter…
I really can't, because there is no information on which age group got which vaccine. The AstraZeneca vaccine has been restricted in the UK for under-30-year-olds as early as April.
Here is a study (Italy) that estimates the risk-reward ratio (fatalities caused vs. prevented) is unfavorable for the entire below-30 age group, including males:
https://www.medrxiv.org/content/10.1101/2021.05.07.21256826v...
> The source I posted is a metastudy, computing IFR based on seroprevalence from many different countries, so PCR tests have nothing to do with it.
This is true, but PCR tests is how we count actual infections and deaths. When calculating the risk of getting infected, IFR alone doesn't help me, I need PCR tests as a metric of how many infections are actually occuring.
Alternatively, I could use seroprevalence: Assuming that seroprevalence is 10% (way higher than in your somewhat outdated source), then over the course of the pandemic, assuming IFR in our cohort is 1:25K, then the absolute risk was 1:250K - roughly on par with the "vaccine fatality" scenario. This is just an example to show that the numbers aren't clearly in favor of the vaccine.